Major Chinese competitor joins the A2 party - Citi

Rebecca Howard
Wed, 06 Nov 2019

A2 Milk will face increased competition after domestic Chinese infant formula player Junlebao launched an A2-protein formula, Citi said in a note.  The stock is down 3.6 percent at $12.30 and Citi maintains a sell rating on the stock as it sees downside to its consensus margins over the medium term, partly due to increasing competition in China. Other risks include an increasing focus on topline growth over short-term profitability, the investment required to capitalise on the US and China opportunities and regulatory and structural headwind...
Opinion FREE
JEHAN CASINADER: Why the diversity debate really matters
Jehan Casinader | Sat, 30 May 2020

When I was an ambitious teenager, desperately trying to get a foothold in the competitive TV news business, the boss of a major current affairs show told me: “You’re the right colour to be on this pro...

BRIAN GAYNOR: Stuff – Deal of the century or has Boucher caught a falling knife?
Brian Gaynor | Fri, 29 May 2020

Sinead Boucher’s purchase of Stuff for just $1 could be the deal of the century.

MARKET CLOSE: NZ shares outperform weaker global markets
Dan Brunskill | Fri, 29 May 2020

New Zealand shares edged higher today as positive earnings counterbalanced a weak lead from Wall Street as investors eyed escalating US-China tensions. The S&P/NZX 50 Index rose 25.72 points, or 0....

Telcos in lockdown, and beyond

Geoff Thorn, CEO, NZ Telecommunications Forum says modern connectivity was a major benefit during lockdown, so it’s important to ensure long term sustainability of the networks